Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Resistance”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00072215
What this trial is testing

Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors

Who this might be right for
Extragonadal Germ Cell TumorTesticular Germ Cell Tumor
Alliance for Clinical Trials in Oncology 1
Testing effectiveness (Phase 2)Ended earlyNCT01352208
What this trial is testing

Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Castrate Resistant Prostate Cancer
Astellas Pharma Inc 13
Testing effectiveness (Phase 2)Looking for participantsNCT07717268
What this trial is testing

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic 51
Post-approval studies (Phase 4)UnknownNCT01572597
What this trial is testing

Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy

Who this might be right for
Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Buddhist Tzu Chi General Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT07292168
What this trial is testing

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

Who this might be right for
Renal Cell Carcinoma MetastaticProstate Cancer MetastaticNon-small Cell Lung Cancer Metastatic+2 more
Kidney Cancer Research Bureau 58
Testing effectiveness (Phase 2)Ended earlyNCT01650350
What this trial is testing

Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer

Who this might be right for
MelanomaProstate CancerRenal Cancer
Brown University 7
Early research (Phase 1)Study completedNCT03136640
What this trial is testing

ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
Modra Pharmaceuticals 23
Large-scale testing (Phase 3)Active Not RecruitingNCT04455750
What this trial is testing

A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
Alliance for Clinical Trials in Oncology 61
Testing effectiveness (Phase 2)Ended earlyNCT01119118
What this trial is testing

ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 6
Early research (Phase 1)Looking for participantsNCT05805371
What this trial is testing

PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
City of Hope Medical Center 21
Large-scale testing (Phase 3)Study completedNCT02260505
What this trial is testing

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

Who this might be right for
Gastrointestinal Stromal TumorsResected Gastrointestinal Stromal TumorsNon-metastatic+2 more
Centre Leon Berard 136
Testing effectiveness (Phase 2)UnknownNCT02935205
What this trial is testing

Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaRecurrent Prostate CarcinomaStage IV Prostate Cancer
Mamta Parikh 38
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Large-scale testing (Phase 3)Looking for participantsNCT06780670
What this trial is testing

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 443
Not applicableUnknownNCT02787837
What this trial is testing

PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.

Who this might be right for
Advanced Prostate CancerAbiraterone ACetate
Centro Nacional de Investigaciones Oncologicas CARLOS III 220
Not applicableUnknownNCT02925702
What this trial is testing

PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.

Who this might be right for
Advanced Prostate CancerCastration ResistantRadium 223
Centro Nacional de Investigaciones Oncologicas CARLOS III 161
Large-scale testing (Phase 3)Study completedNCT03389451
What this trial is testing

68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstatic NeoplasmProstatic Neoplasms, Castration-Resistant+2 more
Michael Graham PhD, MD 30
Testing effectiveness (Phase 2)Ended earlyNCT02414750
What this trial is testing

Vemurafenib Plus Cobimetinib in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Netherlands Working Group on Immunotherapy of Oncology 78
Not applicableLooking for participantsNCT06835218
What this trial is testing

PROCARE - PROstate Cancer Real World Evidence Registry

Who this might be right for
Prostate CancerBiochemical Recurrence of Malignant Neoplasm of ProstateNon-metastatic Castration-resistant Prostate Cancer+2 more
UroTrials Company (GmbH) 5,000
Testing effectiveness (Phase 2)Study completedNCT06056791
What this trial is testing

Study of INKmune in Patients With mCRPC (CaRe Prostate)

Who this might be right for
CancerMetastatic Castration-resistant Prostate CancermCRPC
Inmune Bio, Inc. 12
Next Page